HEADLINES

Malaysia’s economy posts steady 4.4% growth in second quarter

Household spending and investment offset weaker commodity exports

2:24 PM MYT

 

KUALA LUMPUR — Malaysia’s economy grew by 4.4% in the second quarter of 2025, matching the pace recorded in the first three months of the year, the central bank said.

On a seasonally adjusted basis, gross domestic product expanded by 2.1% from the previous quarter, accelerating from 0.7% growth in the first quarter.

Bank Negara Malaysia said, in a statement, robust household spending underpinned the expansion, supported by a healthy labour market and income-related policies such as higher minimum wages and increased salaries for civil servants.

Private and public sector investments also rose more quickly, buoyed by the rollout of new and ongoing projects.

In the external sector, export growth slowed, weighed down by weaker commodity shipments, although this was partly offset by continued demand for electrical and electronics products and strong tourism activity.

Imports grew at a faster pace, driven by higher demand for capital goods linked to investment projects.

On the supply side, the services sector remained the main growth driver, supported by consumer-focused and government services. Manufacturing activity was sustained by steady performance in domestic-oriented industries.

However, overall growth was tempered by a contraction in the mining sector, reflecting lower commodity production. — August 15, 2025

Topics

 

Popular

Port Klang breaks into world’s top 10 busiest ports with 4.1% growth

Malaysia’s largest port overtakes Hong Kong as container volumes climb to 14.64 million TEUs in 2024

Over 1,700 Malaysian products to enjoy zero tariffs under new US trade deal

Palm oil, rubber, cocoa and aerospace equipment among exports covered under the Reciprocal Trade Agreement signed between Malaysia and the United States

Malaysia bans ‘Hong Thai Inhaler’ after Thailand recall over bacterial contamination

Health Ministry blocks online sales and warns public to stop using the unregistered product, citing serious health risks

Related